Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Clinical trial NCT05893693 · UNKNOWN
Trial details
- NCT number
- NCT05893693
- Sponsor
- Aibin Liang，MD，Ph.D.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-12
- Primary completion
- 2026-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.